Mobile: +91 992-500-9739

Tele: +91 79 403-07106

Email: info@newedgeoverseas.com

Agomelatine (Form I & II)

Agomelatine (Form I & II) supplier & exporter

Product Description

API name Agomelatine (Form I & II)
CAS Number 138112-76-2
Therapeutic Category Antidepressant
Route of Administration Tablet
Regulatory Documents TECH PACK, DMF, WC, USDMF, ASMF, CEP, MEXICO DMF, BRAZIL DMF, TAIWAN DMF, KDMF, JDMF

Trader & Wholesaler of Agomelatine (Form I & II)

Mechanism of Action:

The novel antidepressant agent, agomelatine, behaves as an agonist at melatonin receptors (MT1 and MT2) and as an antagonist at serotonin (5-HT)(2C) receptors.

Drug Indications:

Agomelatine is indicated to treat major depressive episodes in adults. Build, train, & validate predictive machine-learning models with structured datasets. Avoid life-threatening adverse drug events & improve clinical decision support

Previous ArticleNext Article